Headquarters
12600 HUMMINGBIRD ST, MUKILTEO, WA 98275-5471, US
MUKILTEO, WA, US
KINEA BIO INC
From the company
Kinea Bio is a Seattle-based biotechnology company founded in 2020 by scientific leaders in the neuromuscular disease space. It is developing next-generation genetic medicine for neuromuscular diseases, including Duchenne Muscular Dystrophy (DMD), dysferlinopathy, and DM1, using AAV-gene therapy approaches such as its Split-Intein Dual-AAV approach and SIMPLI-GT™ technology.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.